Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Immunoglobulin G (IgG) mediates pro- and anti-inflammatory activities through the engagement of its Fc fragment (Fc) with distinct Fcg receptors (FcgRs). One class of Fc-FcgR interactions generates pro-inflammatory effects of immune complexes and cytotoxic antibodies. In contrast, therapeutic intravenous gamma globulin and its Fc fragments are anti-inflammatory. We show here that these distinct properties of the IgG Fc result from differential sialylation of the Fc core polysaccharide. IgG acquires anti-inflammatory properties upon Fc sialylation, which is reduced upon the induction of an antigen-specific immune response. This differential sialylation may provide a switch from innate anti-inflammatory activity in the steady state to generating adaptive pro-inflammatory effects upon antigenic challenge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CREB activation can promote the expression of anti-inflammatory genes while inhibiting inflammatory genes.294,295”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [295]
Citations
Cites
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
Imbach, P., d'APUZZO, V., Hirt, A., Rossi, E., Vest, M., Barandun, S., Baumgartner, C., Morell, A., Schöni, M., & Wagner, H. P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92400-4 · Cited by 1,666
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Fcγ Receptors: Old Friends and New Family Members
Nimmerjahn, F., & Ravetch, J. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.010 · Cited by 1,072
Self-citationAnti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
Self-citationDivergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,037
Self-citationArthritis Critically Dependent on Innate Immune System Players
Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M. A., Boackle, S. A., Takahashi, K., Holers, V. M., Walport, M., Gerard, C., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00275-3 · Cited by 693
FcγRIV: A Novel FcR with Distinct IgG Subclass Specificity
Nimmerjahn, F., Bruhns, P., Horiuchi, K., & Ravetch, J. V. (2005) · Immunity · doi:10.1016/j.immuni.2005.05.010 · Cited by 660
Self-citationManipulating the Immune System with Immune Globulin
Oates, J. A., Wood, A. J. J., & Dwyer, J. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260206 · Cited by 648
Effect of glycosylation on antibody function: implications for genetic engineering
Wright, A., & Morrison, S. L. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(96)10062-7 · Cited by 312
Research works printed but not linked: 1
- M. Holland et al., Biochim. Biophys. Acta1760, 669 (2005).
Cited by
Items 301–400 of 1,003
Autoimmune diseases in the intensive care unit. An update
Quintero, O. L., Rojas‐Villarraga, A., Mantilla, R. D., & Anaya, J. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.06.002 · Cited by 110
Wei, Y., Li, C., Huang, W., Li, B., Strome, S. E., & Wang, L. (2008) · Biochemistry · doi:10.1021/bi800874y · Cited by 109
Ta, H. T., Prabhu, S., Leitner, E., Jia, F., von Elverfeldt, D., Jackson, K. E., Heidt, T., Nair, A. K. N., Pearce, H. A., Mühlen, C. V. Z., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.249375 · Cited by 102
Kemna, M. J., Plomp, R., van Paassen, P., Koeleman, C. A. M., Jansen, B. C., Damoiseaux, J. G. M. C., Tervaert, J. W. C., & Wuhrer, M. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.033 · Cited by 106
Sialylation as an Important Regulator of Antibody Function
Vattepu, R., Sneed, S. L., & Anthony, R. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.818736 · Cited by 118
Espy, C., Morelle, W., Kavian, N., Grange, P., Goulvestre, C., Viallon, V., Chéreau, C., Pagnoux, C., Michalski, J.-C., Guillevin, L., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30362 · Cited by 97
Kurogochi, M., Mori, M., Osumi, K., Tojino, M., Sugawara, S.-I., Takashima, S., Hirose, Y., Tsukimura, W., Mizuno, M., Amano, J., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132848 · Cited by 96
Non-protective immune imprint underlies failure of Staphylococcus aureus IsdB vaccine
Tsai, C., Caldera, J. R., Hajam, I. A., Chiang, A. W. T., Tsai, C.-H., Li, H., Lázaro-Díez, M., Gonzalez, C., Trieu, D., Martins, G. A., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.06.006 · Cited by 107
N-linked glycosylation selectively regulates autonomous precursor BCR function
Übelhart, R., Bach, M. P., Eschbach, C., Wossning, T., Reth, M. G., & Jumaa, H. (2010) · Nature Immunology · doi:10.1038/ni.1903 · Cited by 112
Antibodies and Their Receptors: Different Potential Roles in Mucosal Defense
Horton, R. E., & Vidarsson, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00200 · Cited by 128
Kumpel, B. M. (2007) · Vox Sanguinis · doi:10.1111/j.1423-0410.2007.00945.x · Cited by 104
Shen, X., Klarić, L., Sharapov, S., Mangino, M., Zheng, N., Wu, D., Trbojević‐Akmačić, I., Pučić‐Baković, M., Rudan, I., Polašek, O., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00453-3 · Cited by 104
Antibody glycoengineering strategies in mammalian cells
Wang, Q., Chung, C., Chough, S., & Betenbaugh, M. J. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26567 · Cited by 95
The Clinical Value of Autoantibodies in Rheumatoid Arthritis
Bugatti, S., Manzo, A., Montecucco, C., & Caporali, R. F. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00339 · Cited by 100
Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G
Einarsdottir, H. K., Selman, M. H. J., Kapur, R., Scherjon, S., Koeleman, C. A. M., Deelder, A. M., van der Schoot, C. E., Vidarsson, G., & Wuhrer, M. (2013) · Glycoconjugate Journal · doi:10.1007/s10719-012-9381-6 · Cited by 94
IgEb immune complexes activate macrophages through FcγRIV binding
Hirano, M., Davis, R. S., Fine, W. D., Nakamura, S., Shimizu, K., Yagi, H., Kato, K., Stephan, R. P., & Cooper, M. D. (2007) · Nature Immunology · doi:10.1038/ni1477 · Cited by 94
Glycosylation control technologies for recombinant therapeutic proteins
Gupta, S. K., & Shukla, P. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9430-6 · Cited by 105
Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists
Buonpane, R. A., Churchill, H. R. O., Jalali, B. M., Sundberg, E. J., Peterson, M. L., Schlievert, P. M., & Kranz, D. M. (2007) · Nature Medicine · doi:10.1038/nm1584 · Cited by 93
Neonatal Fc Receptor Blockade by Fc Engineering Ameliorates Arthritis in a Murine Model
Patel, D. A., Puig-Canto, A., Challa, D. K., Montoyo, H. P., Ober, R. J., & Ward, E. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003780 · Cited by 93
The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivo
Anthony, R. M., & Nimmerjahn, F. (2011) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328342538f · Cited by 93
Self-citationExtra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
Boudreau, C. M., & Alter, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00440 · Cited by 97
van Berkel, P. H. C., Gerritsen, J., Perdok, G., Valbjørn, J., Vink, T., van de Winkel, J. G. J., & Parren, P. W. H. I. (2009) · Biotechnology Progress · doi:10.1002/btpr.92 · Cited by 92
Ohyanagi, T., Nagahori, N., Shimawaki, K., Hinou, H., Yamashita, T., Sasaki, A., Jin, T., Iwanaga, T., Kinjo, M., & Nishimura, S. (2011) · Journal of the American Chemical Society · doi:10.1021/ja111201c · Cited by 94
Glycan characterization of biopharmaceuticals: Updates and perspectives
Planinc, A., Bones, J., Dejaegher, B., Antwerpen, P. V., & Delporte, C. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2016.03.049 · Cited by 103
Fc gamma receptors: glycobiology and therapeutic prospects
Hayes, J. M., Wormald, M. R., Rudd, P. M., & Davey, G. P. (2016) · Journal of Inflammation Research · doi:10.2147/jir.s121233 · Cited by 103
The other side of immunoglobulin G: suppressor of inflammation
Aschermann, S., Lux, A., Baerenwaldt, A., Biburger, M., & Nimmerjahn, F. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.04081.x · Cited by 91
Self-citationAntibody glycosylation in autoimmune diseases
Zhou, X., Motta, F., Selmi, C. F., Ridgway, W. M., Gershwin, M. E., & Zhang, W. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102804 · Cited by 100
Buhre, J. S., Pongrácz, T., Künsting, I., Lixenfeld, A. S., Wang, W., Nouta, J., Lehrian, S., Schmelter, F., Lunding, H. B., Dühring, L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1020844 · Cited by 103
Sack, M., Paetz, A., Kunert, R., Bomble, M., Hesse, F., Stiegler, G. M., Fischer, R., Katinger, H. W. D., Stoeger, E., & Rademacher, T. (2007) · The FASEB Journal · doi:10.1096/fj.06-5863com · Cited by 103
Infection, inflammation and host carbohydrates: A Glyco-Evasion Hypothesis
Kreisman, L. S. C., & Cobb, B. A. (2012) · Glycobiology · doi:10.1093/glycob/cws070 · Cited by 101
Poduslo, J. F., Ramakrishnan, M., Holasek, S. S., Ramirez‐Alvarado, M., Kandimalla, K. K., Gilles, E. J., Curran, G. L., & Wengenack, T. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04591.x · Cited by 89
IgG-effector functions: “The Good, The Bad and The Ugly”
Kapur, R., Einarsdottir, H., & Vidarsson, G. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.01.015 · Cited by 118
Immune Thrombocytopenic Purpura
Psaila, B., & Bussel, J. B. (2007) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2007.06.007 · Cited by 89
Structural analysis of Fc/FcγR complexes: a blueprint for antibody design
Caaveiro, J. M. M., Kiyoshi, M., & Tsumoto, K. (2015) · Immunological Reviews · doi:10.1111/imr.12365 · Cited by 103
Molecular mass and chain conformations of Rhizoma Panacis Japonici polysaccharides
Huang, Z., Huang, Y., Li, X., & Zhang, L. (2009) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2009.05.027 · Cited by 93
Branch-Specific Sialylation of IgG-Fc Glycans by ST6Gal-I
Barb, A. W., Brady, E. K., & Prestegard, J. H. (2009) · Biochemistry · doi:10.1021/bi901430h · Cited by 88
Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapy
Jandus, C., Simon, H., & von Gunten, S. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.018 · Cited by 103
Mnatsakanyan, R., Shema, G., Basik, M., Batist, G., Borchers, C. H., Sickmann, A., & Zahedi, R. P. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1483340 · Cited by 95
Xiao, L., Zhang, L., Guo, C., Xin, Q., Gu, X., Jiang, C., & Wu, J. (2024) · 癌症:英文版 · doi:10.1002/cac2.12579 · Cited by 96
Crystal Structure of Fcγ Receptor I and Its Implication in High Affinity γ-Immunoglobulin Binding
Lu, J., Ellsworth, J. L., Hamacher, N., Oak, S. W., & Sun, P. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257550 · Cited by 87
Translating basic mechanisms of IgG effector activity into next generation cancer therapies.
Nimmerjahn, F., & Ravetch, J. V. (2012) · Europe PMC (PubMed Central) · Cited by 99
Self-citationCrow, A. R., & Lazarus, A. H. (2008) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2007.12.001 · Cited by 96
Human Fc Receptor–Like 5 Binds Intact IgG via Mechanisms Distinct from Those of Fc Receptors
Franco, A., Damdinsuren, B., Ise, T., Dement-Brown, J., Li, H., Nagata, S., & Tolnay, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202860 · Cited by 85
“Deglycosylated IgG1 and IgG2 were produced using PNGase F (New England Biolabs, Ipswich, MA) to remove N-linked oligosaccharides (25).”
MethodRegulatory functions of B cells in allergic diseases
Braza, F., Chesné, J., Castagnet, S., Magnan, A., & Brouard, S. (2014) · Allergy · doi:10.1111/all.12490 · Cited by 96
Long pentraxin 3: A novel multifaceted player in cancer
Giacomini, A., Ghedini, G. C., Presta, M., & Ronca, R. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.11.004 · Cited by 90
Sweet but dangerous – the role of immunoglobulin G glycosylation in autoimmunity and inflammation
Biermann, M. H. C., Griffante, G., Podolska, M. J., Boeltz, S., Stürmer, J., Munoz, L. E., Bilyy, R. O., & i, M. H. (2016) · Lupus · doi:10.1177/0961203316640368 · Cited by 97
Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies
Yu, X., Baruah, K., Harvey, D. J., Vasiljevic, S., Alonzi, D. S., Song, B.-D., Higgins, M. K., Bowden, T. A., Scanlan, C. N., & Crispin, M. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4014375 · Cited by 84
Using glyco-engineering to produce therapeutic proteins
Dicker, M., & Strasser, R. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1069271 · Cited by 89
Wagner‐Rousset, E., Bednarczyk, A., Bussat, M., Colas, O., Corvaïa, N., Schaeffer‐Reiss, C., DORSSELAER, A. V., & Beck, A. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.03.032 · Cited by 89
Role of natural antibodies in immune homeostasis: IVIg perspective
Vani, J., Elluru, S. R., Negi, V.-S., Lacroix‐Desmazes, S., Kazatchkine, M. D., Bayry, J., & Kaveri, S. V. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.04.011 · Cited by 84
Impact of Differential Glycosylation on IgG Activity
Lux, A., & Nimmerjahn, F. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5632-3_10 · Cited by 91
Self-citationIdentification of manipulated variables for a glycosylation control strategy
St. Amand, M. M., Radhakrishnan, D., Robinson, A. S., & Ogunnaike, B. A. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25251 · Cited by 83
Current therapy of the pemphigus group
Kasperkiewicz, M., Schmidt, E., & Zillikens, D. (2011) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2011.03.014 · Cited by 83
The promise of protein glycosylation for personalised medicine
Almeida, A., & Kolarich, D. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.03.012 · Cited by 100
Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab)
Hong, J. H., Lee, Y., Lee, C., Eo, S., Kim, S.-Y., Lee, N., Park, J.-M., Park, S.-K., Seo, D., Jeong, M., et al. (2016) · mAbs · doi:10.1080/19420862.2016.1264550 · Cited by 89
Sugar Determines Antibody Activity
Burton, D. R., & Dwek, R. A. (2006) · Science · doi:10.1126/science.1131712 · Cited by 92
Fc Sialylation Prolongs Serum Half-Life of Therapeutic Antibodies
Bas, M., Terrier, A., Jacque, E., Dehenne, A., Pochet-Béghin, V., Beghin, C., Dezetter, A.-S., Dupont, G., Engrand, A., Beaufils, B., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800896 · Cited by 82
Amino Acids, Peptides, and Proteins
Dietzen, D. J. (2018) · Principles and Applications of Molecular Diagnostics · doi:10.1016/b978-0-12-816061-9.00013-8 · Cited by 82
Subedi, G. P., Hanson, Q. M., & Barb, A. W. (2014) · Structure · doi:10.1016/j.str.2014.08.002 · Cited by 81
“…Fc wt:FcγRIIIa affinity, as measured by surface plasmon resonance (SPR; 0.55±0.05 μM), isothermal titration calorimetry (ITC; 1.2±0.1 μM) and a Protein A resin-based pull down assay (0.5 μM), was similar to reported values (0.1–2 μM (Kaneko et al., 2006; Yamaguchi et al., 2006; Yu et al., 2013)).”
BackgroundResultInfluentialRosati, S., van den Bremer, E. T., Schuurman, J., Parren, P. W., Kamerling, J. P., & Heck, A. J. (2013) · mAbs · doi:10.4161/mabs.26282 · Cited by 81
Microheterogeneity of Recombinant Antibodies: Analytics and Functional Impact
Beyer, B., Schuster, M., Jungbauer, A., & Lingg, N. (2017) · Biotechnology Journal · doi:10.1002/biot.201700476 · Cited by 92
Zhou, J. Y., Oswald, D. M., Oliva, K. D., Kreisman, L. S. C., & Cobb, B. A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.04.004 · Cited by 89
IgG Fc Glycosylation in Human Immunity
Wang, T. T. (2019) · Current topics in microbiology and immunology · doi:10.1007/82_2019_152 · Cited by 99
Cancer-derived sialylated IgG promotes tumor immune escape by binding to Siglecs on effector T cells
Wang, Z., Geng, Z., Shao, W., Liu, E., Zhang, J., Tang, J., Wang, P., Sun, X., Xiao, L., Xu, W., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0327-9 · Cited by 84
Protein Glycoengineering: An Approach for Improving Protein Properties
Ma, B., Guan, X., Li, Y., Shang, S., Li, J., & Tan, Z. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00622 · Cited by 91
Expression and glycoengineering of functionally active heteromultimeric IgM in plants
Loos, A., Grünwald‐Gruber, C., Altmann, F., Mehofer, U., Hensel, F., Grandits, M., Oostenbrink, C., Stadlmayr, G., Furtmüller, P. G., & Steinkellner, H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320544111 · Cited by 81
Modulating Antibody Functionality in Infectious Disease and Vaccination
Gunn, B. M., & Alter, G. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.09.002 · Cited by 79
Naegeli, A., Neupert, C., Fan, Y., Lin, C., Poljak, K., Papini, A. M., Schwarz, F., & Aebi, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.524462 · Cited by 82
The immunopathogenesis of immune thrombocytopenia
Semple, J. W., & Provan, D. (2012) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283567541 · Cited by 80
Hmiel, L. K., Brorson, K., & Boyne, M. T. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8108-x · Cited by 92
Chronic Inflammatory Demyelinating Polyneuropathy
Dimachkie, M. M., & Barohn, R. J. (2013) · Current Treatment Options in Neurology · doi:10.1007/s11940-013-0229-6 · Cited by 80
B Cells and Immunological Tolerance
Manjarrez‐Orduño, N., Quách, T. D., & Sanz, I. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.240 · Cited by 93
Membrane adsorbers comprising grafted glycopolymers for targeted lectin binding
Chenette, H. C. S., & Husson, S. M. (2014) · Journal of Applied Polymer Science · doi:10.1002/app.41437 · Cited by 79
Largy, E., Cantais, F., Vyncht, G. V., Beck, A., & Delobel, A. (2017) · Journal of Chromatography A · doi:10.1016/j.chroma.2017.02.072 · Cited by 84
High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
Hoffmann, J. H. O., & Enk, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01090 · Cited by 78
Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity
Earnest, J. T., Basore, K., Roy, V., Bailey, A. L., Wang, D., Alter, G., Fremont, D. H., & Diamond, M. S. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20190736 · Cited by 78
Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies
Jacob, S., & Rajabally, Y. A. (2009) · Current Neuropharmacology · doi:10.2174/157015909790031166 · Cited by 79
Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
Li, W., Zhu, Z., Chen, W., Feng, Y., & Dimitrov, D. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01554 · Cited by 78
Core Fucosylation of IgG B Cell Receptor Is Required for Antigen Recognition and Antibody Production
Li, W., Yu, R., Ma, B., Yang, Y., Jiao, X., Liu, Y., Cao, H., Dong, W., Liu, L., Ma, K., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402678 · Cited by 78
Stepping stones in DNA sequencing
Stranneheim, H., & Lundeberg, J. (2012) · Biotechnology Journal · doi:10.1002/biot.201200153 · Cited by 94
Immunoglobulin G1 Fc Domain Motions: Implications for Fc Engineering
Frank, M., Walker, R. C., Lanzilotta, W. N., Prestegard, J. H., & Barb, A. W. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.01.011 · Cited by 77
Low-affinity Fcγ receptors, autoimmunity and infection
Willcocks, L. C., Smith, K. G. C., & Clatworthy, M. R. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001161 · Cited by 81
Response of Dystrophic Calcification to Intravenous Immunoglobulin
Schanz, S. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.5.585 · Cited by 78
Espéli, M., Smith, K. G. C., & Clatworthy, M. R. (2015) · Immunological Reviews · doi:10.1111/imr.12368 · Cited by 83
Mechanisms of tolerance induction in allergic disease: integrating current and emerging concepts
Wiśniewski, J., Agrawal, R., & Woodfolk, J. A. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12016 · Cited by 89
Complex genetic regulation of proteinglycosylation
Lauc, G., Rudan, I., Campbell, H. J., & Rudd, P. M. (2009) · Molecular BioSystems · doi:10.1039/b910377e · Cited by 90
GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins
Beck, A., Cochet, O., & Wurch, T. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903413504 · Cited by 77
Sjöwall, C., Zapf, J., von Löhneysen, S., Magorivska, I., Biermann, M. H. C., Janko, C., Winkler, S., Bilyy, R. O., Schett, G. A., i, M. H., et al. (2014) · Lupus · doi:10.1177/0961203314558861 · Cited by 81
Guptill, J. T., Soni, M., & Meriggioli, M. N. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0398-y · Cited by 86
Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale
Fehr, T. H., & Gaspert, A. (2012) · Transplant International · doi:10.1111/j.1432-2277.2012.01453.x · Cited by 76
With or Without Sugar? (A)glycosylation of Therapeutic Antibodies
Hristodorov, D., Fischer, R., & Lindén, L. (2012) · Molecular Biotechnology · doi:10.1007/s12033-012-9612-x · Cited by 80
Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside
Zandman‐Goddard, G., Blank, M., & Shoenfeld, Y. (2009) · Lupus · doi:10.1177/0961203309106921 · Cited by 75
Multiplexed Analytical Glycomics: Rapid and Confident IgG N-Glycan Structural Elucidation
Mittermayr, S., Bones, J., Doherty, M., Guttman, A., & Rudd, P. M. (2011) · Journal of Proteome Research · doi:10.1021/pr200371s · Cited by 75
Shortage of human intravenous immunoglobulin—reasons and possible solutions
Bayry, J., Kazatchkine, M. D., & Kaveri, S. V. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0429 · Cited by 76
Glycoengineered antibodies: towards the next-generation of immunotherapeutics
Mastrangeli, R., Palinsky, W., & Bierau, H. (2018) · Glycobiology · doi:10.1093/glycob/cwy092 · Cited by 84
Zhang, W., Wang, H., Feng, N., Li, Y., Gu, J., & Wang, Z. (2022) · Antibody Therapeutics · doi:10.1093/abt/tbac029 · Cited by 107
Glycosylation as a marker for inflammatory arthritis
Albrecht, S., Unwin, L., Muniyappa, M., & Rudd, P. M. (2014) · Cancer Biomarkers · doi:10.3233/cbm-130373 · Cited by 76
Immunoglobulin genetics and antibody responses to influenza in ducks
Magor, K. E. (2011) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2011.02.011 · Cited by 76
Engineering host cell lines to reduce terminal sialylation of secreted antibodies
Naso, M. F., Tam, S. H., Scallon, B. J., & Raju, T. S. (2010) · mAbs · doi:10.4161/mabs.2.5.13078 · Cited by 74
Electrochemical lectin based biosensors as a label-free tool in glycomics
Bertók, T., Katrlík, J., Gemeiner, P., & Tkáč, J. (2012) · Microchimica Acta · doi:10.1007/s00604-012-0876-4 · Cited by 77
Metadata
- Authors
- Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Rockefeller University (US)
- Corresponding author
- Kaneko, Yoshikatsu
- Nimmerjahn, Falk
- Ravetch, Jeffrey V.
- Venue
- Science
- Published
- 2006-08-04
- Volume
- 313
- Issue
- 5787
- Pages
- 670-673
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2035433348
- Cited by
- 1,754
- References
- 21
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 63 · 2023: 67 · 2022: 77 · 2021: 101 · 2020: 103 · 2019: 93 · 2018: 97 · 2017: 89 · 2016: 96 · 2015: 105 · 2014: 122 · 2013: 113 · 2012: 98
- FWCI
- 71.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IgG, Fc fragment, anti-inflammatory activity, Fc gamma receptor, immune complexes, intravenous immunoglobulin, antigen-specific immune response, innate immunity, adaptive immunity, pro-inflammatory effects
- MeSH terms
- Animals, Antibodies, Monoclonal, Arthritis, Arthritis, Rheumatoid, Glycosylation, Half-Life, Immunoglobulin G, Immunoglobulin Fc Fragments, Inflammation, Mice, Inbred C57BL, Nephritis, Polysaccharides, Receptors, Fc, Sialic Acids, Mice, Inbred NOD, Immunoglobulins, Intravenous, Receptors, IgG, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.